Navigation Links
Life Technologies and ProBioGen AG Announce Freedom™ Cell Line Development Royalty-Free Kits To Advance Early Stage Biologic Drug Production
Date:5/17/2011

CARLSBAD, Calif. and BERLIN, May 17, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) and ProBioGen AG today announced the availability of Gibco® Freedom™ Cell Line Development Kits, a new line of royalty-free products that integrate cells, reagents, culture media and protocols to bring simplicity and flexibility, eliminating up to two months in the earliest stages of new biological drug development.  These kits make it easier and faster to bring new molecules to the market.

Life Technologies' new kits can reduce the time from transfection to stable cell line production, from six to four months, making unprecedented use of a single, optimized, animal-free culture medium throughout the entire development process.  This eliminates the need for multiple time consuming and complicated media adaptation steps.

"Life Technologies' cell line development kits showcase our ability to integrate proprietary technologies into simple, innovative solutions that accelerate the pathway from molecule to market," said Mark Stevenson, President and Chief Operating Officer of Life Technologies. "Our royalty-free Freedom™ kits enable faster early stage development, and allow customers to focus on what they do best—developing new biologics to treat diseases."

The Freedom™ CHO-S™ and DG44 Kits provide biopharmaceutical drug development teams with key components for biotech and pharmaceutical companies to rapidly and systematically generate Chinese Hamster Ovary (CHO) cell lines to produce clinical and commercial biologic pharmaceuticals. CHO cells have been engineered to express recombinant proteins as therapeutics for a wide range of diseases, including rheumatoid arthritis, anemia, multiple scl
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2011 Results
2. Palatin Technologies, Inc. Announces Results of Annual Stockholders Meeting
3. Life Technologies Employees Give Back to Their Communities During Eighth Annual Global Volunteer Day
4. Micell Technologies Reports Preclinical Data for MiStent™ Drug-Eluting Coronary Stent to be Presented at EuroPCR
5. Terumo Americas Holding, Inc., Agrees to Acquire Harvest Technologies Corporation, a Leader in the Development of Point-of-Care Cellular Therapy
6. BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial Results
7. Netsmart Technologies Names Michael Valentine as Chief Executive Officer
8. Caliper Owners Group and Investor Meeting to Highlight Technologies Enabling Personalized Medicine
9. Reportlinker Adds Biomarkers: Technologies and Global Markets
10. Reportlinker Adds Medical Enzymes: Technologies and Global Markets
11. Life Technologies Names Dr. Ora Hirsch Pescovitz to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  Now available is ... home. Rehealth Regenerative Therapies , located in ... other physically active people a new health option: ... Regardless of age, countless patients suffer from joint and ... such as muscle tears, torn rotator cuff, tennis elbow, ...
(Date:7/24/2014)... July 24, 2014  ECC West Africa, LLC (ECC) ... with University College Hospital (UCH) Ibadan Board of ... to finance, design, construct, and operate and maintain a ... . Under the first of the 4-phase project, ... and funding applications. UCH Ibadan intends to finance and ...
(Date:7/24/2014)... research team led by group leader Yung-Eun Sung ... to synthesize sulfur-doped and nitrogen-doped graphenes which can ... batteries and fuel cells. Yung-Eun Sung is both ... Research at Institute for Basic Science* (IBS) and ... This achievement has great significance with regards to ...
(Date:7/24/2014)... Engineering at the University of Delaware, is known ... energy engineering, environmental sustainability and electronics. , His ... with a well-defined, crystalline structure. At the atomic ... that zeolites can separate molecules with size differences ... of a nanometer), making them useful to the ...
Breaking Biology Technology:Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2University of Delaware researcher describes new approach for creating organic zeolites 2
... 10 MedImmune today announced that,researchers will present ... the Annual Meeting of the American Association for,Cancer ... oncology research., "Cancer research has long been ... we,are proud to share data from our increasingly ...
... NEW YORK, April 10 Intellect Neurosciences,Inc. (OTC ... obtained a,Notice of Allowance and completed the grant ... Company,s ANTISENILIN(R) antibodies and,products being developed by the ... the European patent is expected in several weeks. ...
... (Nasdaq:,INSM), a developer of follow-on biologics and biopharmaceuticals, ... the Chairman and,Ranking Member of the U.S. House ... of legislation to establish a Follow-On,Biologics (FOBs) regulatory ... the biotechnology industry,healthcare and patient communities, the letter ...
Cached Biology Technology:MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research 2MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research 3Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimer's Disease 2Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimer's Disease 3Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimer's Disease 4Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway 2Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway 3
(Date:7/24/2014)... have decreased by 45% on average over a 35 ... a study on the impact of humans on declining ... benefits invertebrates such as insects, spiders, crustaceans, slugs and ... pest control for crops, decomposition for nutrient cycling, water ... Science and led by UCL, Stanford and ...
(Date:7/24/2014)... biodiversity, the product of 3.5 billion years of evolutionary ... of life. But it may be reaching a tipping ... and analysis of data published in Science , ... and decline of animals is contributing to what appears ... mass biological extinction event. , Since 1500, more than ...
(Date:7/24/2014)... Albert Einstein College of Medicine of Yeshiva ... Fox Foundation for Parkinson,s Research to translate a basic ... drug discovery project will test chemical compounds on a ... drug that acts on an underlying cause of the ... many people manage their symptoms, we are eager to ...
Breaking Biology News(10 mins):Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3Stanford biologist warns of early stages of Earth's 6th mass extinction event 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 3Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 2Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 3
... a mathematical model of how cells pack together to form ... no model is universal. Researchers at Northwestern University have ... -- to show how cells pack together to create the ... hope that the pared-down equation can be applied to different ...
... Louis is partnering with Chrysler LLC and a ... if paint solid residues from automobile manufacturing can reduce ... project is based upon the technical expertise of Pratim ... Engineering Science, who has demonstrated the effectiveness of titanium ...
... Nucleonics, Inc., a privately held biotechnology company ... (RNAi)-based therapeutics, announced today that the company has ... safety study of its experimental treatment for chronic ... NUC B1000 ( http://www.nucleonicsinc.com/products/hepb.html ) is an ...
Cached Biology News:Researchers create mathematical model of fruit fly eyes 2Washington University, 2 industries, team to clean up mercury emissions 2Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic 2Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic 3
Rabbit polyclonal to Yaf9 ( Abpromise for all tested applications)....
... deparaffinize and perform Heat Induced Antigen Retrieval ... mounted on glass microscope slides. Deparffinization is ... high temperature used in HIER (over 90degrees ... by detergent. Formaldehyde fixation impairs or totally ...
... Calf Serum; U.S. sourced, ideal ... uncompromising quality; Low hemoglobin; Endotoxin: ... animals of US origin; U.S. ... seek an uncompromising quality. Low ...
Collected from animals of U.S. origin.Collected from animals of U.S. origin. *Can be used in cell growth studies and immunoassays. *Sterility tested, * Mycoplasma tested upon request, *Endoto...
Biology Products: